The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1,3-Di((1H-benzo[d]1,2,3-triazol-1-yl)methyl)benzimidazolium chloride ID: ALA3759812
PubChem CID: 127028659
Max Phase: Preclinical
Molecular Formula: C21H17ClN8
Molecular Weight: 381.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: [Cl-].c1ccc2c(c1)nnn2Cn1c[n+](Cn2nnc3ccccc32)c2ccccc21
Standard InChI: InChI=1S/C21H17N8.ClH/c1-3-9-18-16(7-1)22-24-28(18)14-26-13-27(21-12-6-5-11-20(21)26)15-29-19-10-4-2-8-17(19)23-25-29;/h1-13H,14-15H2;1H/q+1;/p-1
Standard InChI Key: QOJQKMRAXOPHJQ-UHFFFAOYSA-M
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
9.1402 0.0044 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1812 2.6271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6500 2.9355 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7144 1.9316 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0239 2.6686 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7256 4.1318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2395 4.2946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6192 5.6647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5233 6.8862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0094 6.7235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6277 5.3353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1855 -2.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6552 -2.9294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7165 -1.9222 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0283 -2.6552 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7345 -4.1193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2488 -4.2866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6328 -5.6586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5406 -6.8774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0262 -6.7101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6402 -5.3200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
2 6 1 0
7 8 1 0
8 9 2 0
9 10 1 0
5 10 2 0
4 7 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
12 16 1 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
16 17 2 0
11 12 1 0
3 11 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 1 0
22 26 1 0
27 28 1 0
28 29 2 0
29 30 1 0
25 30 2 0
26 27 2 0
21 22 1 0
6 21 1 0
M CHG 2 1 -1 3 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 381.42Molecular Weight (Monoisotopic): 381.1571AlogP: 2.43#Rotatable Bonds: 4Polar Surface Area: 70.23Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 0.56CX LogP: 0.31CX LogD: 0.31Aromatic Rings: 6Heavy Atoms: 29QED Weighted: 0.44Np Likeness Score: -0.92
References 1. Karataş MO, Uslu H, Alıcı B, Gökçe B, Gencer N, Arslan O, Arslan NB, Özdemir N.. (2016) Functionalized imidazolium and benzimidazolium salts as paraoxonase 1 inhibitors: Synthesis, characterization and molecular docking studies., 24 (6): [PMID:26879855 ] [10.1016/j.bmc.2016.02.012 ]